Dr. Hanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
S-20
Cleveland, OH 44195Phone+1 216-444-0663- Is this information wrong?
Summary
- Dr. Rabi Hanna is the chairman of pediatric hematology-oncology department and the medical director of pediatric BMT program at Cleveland Clinic Children's. He received his medical degree from University of Aleppo Faculty of Medicine in 2001. He speaks multiple languages, including Arabic and Assyrian. He is experienced in aplastic anemia, bone marrow transplantation, pediatric hematology and oncology, sickle cell disease, and stem cell transplantation. His research focus on alternative donor and novel therapies for non-malignant disorders including Gene therapies.
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Duke University HospitalResidency, Pediatrics, 2004 - 2007
- University of Aleppo Faculty of MedicineClass of 2001
Certifications & Licensure
- OH State Medical License 2010 - 2024
- MI State Medical License 2017 - 2021
- NY State Medical License 2017 - 2019
- WA State Medical License 2007 - 2011
- NC State Medical License 2004 - 2007
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Corkery Fellowship Award Seattle / FHCRC, 2009
- James A. Stockman III Award Duke University, 2007
- Deborah Kredich Award 2006
- Join now to see all
Clinical Trials
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders Start of enrollment: 2006 Jun 01
- MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention Start of enrollment: 2014 Jul 07
- Join now to see all
Publications & Presentations
PubMed
- An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina Wilkerson, Ali Alahmari, Adriana Seber, Carmem M S Bonfim, Belinda Pinto Simões, Mohsen Alzahrani, Michael J Eck...> ;Blood. 2024 Mar 17
- 6 citationsImmune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.Rezvani, A. R., Paul Szabolcs, Roei D Mazor, Dima Yackoubov, Stuart Levy, Patrick Stiff, Andrew Rezvani, Rabi Hanna, John Wagner, Amy Keating, Caroline A Lindemans, Ni...> ;Transplantation and Cellular Therapy. 2023 Aug 1
- Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J Rotz, Robert M Dean, Aaron T Gerds, Deepa Ja...> ;Blood Advances. 2023 Aug 22
- Join now to see all
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
- Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic SyndromesSamuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood
- Join now to see all
Abstracts/Posters
- No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...Rabi Hanna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Rabi Hanna, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Risk factors for infections in recipients of hematopoietic cell transplantation in relation to donor sourceAron Flagg, Rabi Hanna, Lisa A. Rybicki, Sherif B. Mossad, Betty Ky Hamilton, Aaron T. Gerds, Ronald Sobecks, Hien Duong, Steven Andresen, Brian Bolwell, Navneet S Maj..., ASBMT, 1/1/2014
- Join now to see all
Press Mentions
- How Thalassemia Gene Therapy Approval Is Making a DifferenceMay 8th, 2023
- Substantial Variability Exists in International Consensus Definitions for Pediatric ALL Trial OutcomesFebruary 3rd, 2023
- As World Sickle Cell Day Is Marked, Major Advances in Treatments Offer Hope to Millions of Patients WorldwideJune 16th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Arabic, Assyrian
Hospital Affiliations
- Cleveland ClinicCleveland, Ohio
- Cleveland Clinic Children's Hospital for RehabilitationCleveland, Ohio
- Cleveland Clinic Childrens HospitalCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: